Conventional versus molecular methods for the detection of Clostridium difficile

Journal of Clinical Microbiology

Volumn 49, Issue 9 SUPPL., 2011, Pages

  Carroll, Karen C ^a   Loeffelholz, Michael ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MOXIFLOXACIN; PROTON PUMP INHIBITOR; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

AGE DISTRIBUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM DETECTION; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CELL ADHESION; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; COLON RESECTION; CONFERENCE PAPER; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; DISEASE SEVERITY; EPIDEMIC; GEOGRAPHIC DISTRIBUTION; HEALTH CARE COST; HIGH RISK POPULATION; HUMAN; IMMUNOCOMPROMISED PATIENT; INFECTION RISK; INTERMETHOD COMPARISON; MOLECULAR DIAGNOSIS; MORTALITY; NONHUMAN; PATHOGENICITY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR;

CLOSTRIDIUM DIFFICILE;

EID: 80053208686     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00700-11     Document Type: Conference Paper

References (27)

1. Aichinger, E., C. D. Schleck, W. S. Harmsen, L. M. Nyre, and R. Patel. 2008. Nonutility of repeat laboratory testing for detection of Clostridium difficile by use of PCR or enzyme immunoassay. J. Clin. Microbiol. 46:3795-3797.
2. Akerlund, T., et al. 2008. Increased sporulation rate of epidemic Clostridium difficile type 027/NAP1. J. Clin. Microbiol. 46:1530-1533. (Pubitemid 351563610)
3. Bouza, E., et al. 2001. "Second-look" cytotoxicity: an evaluation of culture plus cytotoxin assay of Clostridium difficile isolates in the laboratory diagnosis of CDAD. J. Hosp. Infect. 48:233-237. (Pubitemid 32680863)
4. Carroll, K. C. 3 March 2011, posting date. Tests for the diagnosis of Clostridium difficile infections. The next generation. Anaerobe [Epub ahead of print.] doi:10.1016/j.anaerobe.2011.01.002.
5. Cohen, S. H., et al. 2010. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America. Infect. Control Hosp. Epidemiol. 31:431-455.
6. Crobach, M. J. T., O. M. Dekkers, M. H. Wilcox, and E. J. Kuijper. 2009. European Society of Clinical Microbiology and Infectious Diseases (ESCMID): data review and recommendations for diagnosing Clostridium difficile-infection (CDI). Clin. Microbiol. Infect. 15:1053-1066.
7. DuPont, H. L. 2011. The search for effective treatment of Clostridium difficile infection. N. Engl. J. Med. 364:473-475.
8. Eastwood, K., P. P. Else, A. Charlett, and M. Wilcox. 2009. Comparison of nine commercially available Clostridium difficile toxin detection assays, a real-time PCR assay for C. difficile tcdB, and a glutamate dehydrogenase detection assay to cytotoxin testing and cytotoxigenic culture methods. J. Clin. Microbiol. 47:3211-3217.
9. Fenner, L., A. F. Widmer, G. Goy, S. Rudin, and R. Frei. 2008. Rapid and reliable diagnostic algorithm for detection of Clostridium difficile. J. Clin. Microbiol. 46:328-330.
10. Freeman, J., et al. 2010. The changing epidemiology of Clostridium difficile infections. Clin. Microbiol. Rev. 23:529-549.
11. Gerding, D. N. 2010. Global epidemiology of Clostridium difficile infection in 2010. Infect. Control Hosp. Epidemiol. 31(Suppl. 1):S32-S34.
12. Leonard, J., J. K. Marshall, and P. Moayyedi. 2007. Systematic review of the risk of enteric infection in patients taking acid suppression. Am. J. Gastroenterol. 102:2047-2056. (Pubitemid 47301504)
13. Loo, V. G., et al. 2005. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N. Engl. J. Med. 353:2442-2449. (Pubitemid 41770165)
14. McDonald, L. C., et al. 2005. An epidemic, toxin gene-variant strain of Clostridium difficile. N. Engl. J. Med. 353:2433-2441. (Pubitemid 41770164)
15. Novak-Weekley, S. M., et al. 2010. Clostridium difficile testing in the clinical laboratory by use of multiple testing algorithms. J. Clin. Microbiol. 48:889-893.
16. Peterson, L. R., and A. Robicsek. 2009. Does my patient have Clostridium difficile infection? Ann. Intern. Med. 151:176-179.
17. Planche, T., et al. 2008. Diagnosis of Clostridium difficile infection by toxin detection kits: a systematic review. Lancet Infect. Dis. 8:777-784.
18. Quinn, C. D., et al. 2010. C. Diff Quik Chek complete enzyme immunoassay provides a reliable first-line method for detection of Clostridium difficile in stool specimens. J. Clin. Microbiol. 48:603-605.
19. Reller, M. E., et al. 2007. Yield of stool culture with isolate toxin testing versus a two-step algorithm including stool toxin testing for detection of toxigenic Clostridium difficile. J. Clin. Microbiol. 45:3601-3605. (Pubitemid 350156855)
20. Schwan, C., et al. 2009. Clostridium difficile toxin CDT induces formation of microtubule-based protrusions and increases adherence of bacteria. PLoS Pathog. 5:1-14.
21. Sebaihia, M., et al. 2006. The multi-drug resistant human pathogen Clostridium difficile has a highly mobile, mosaic genome. Nat. Genet. 38:779-786. (Pubitemid 43980598)
22. Sharp, S. E., et al. 2010. Evaluation of the C.Diff Quik Chek Complete assay, a new glutamate dehydrogenase and A/B toxin combination lateral flow assay for use in rapid, simple diagnosis of Clostridium difficile disease. J. Clin. Microbiol. 48:2082-2086.
23. Shetty, N., M. W. D. Wren, and P. G. Coen. 2011. The role of glutamate dehydrogenase for the detection of Clostridium difficile in faecal samples: a meta-analysis. J. Hosp. Infect. 77:1-6.
24. Stabler, R. A., et al. 2006. Comparative phylogenomics of Clostridium difficile reveals clade specificity and microevolution of hypervirulent strains. J. Bacteriol. 188:7297-7305. (Pubitemid 44547635)
25. Swindells, J., N. Brenwald, N. Reading, and B. Oppenheim. 2010. Evaluation of diagnostic tests for Clostridium difficile infection. J. Clin. Microbiol. 48: 606-608.
26. Tenover, F. C., et al. 2010. Impact of strain type on detection of toxigenic Clostridium difficile: comparison of molecular diagnostic and enzyme immunoassay approaches. J. Clin. Microbiol. 48:3719-3724.
27. Warny, M., et al. 2005. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 366:1079-1084. (Pubitemid 41338761)